KnowTheStock
Log inCreate free account

DEXCOM INC

DXCM
S&P 500Nasdaq 100Surgical & Medical Instruments & Apparatus · Nasdaq
$69.98last close · market cap 27.30 Billion
Compare with…
75.4SCORE / 100
Our verdictHOLDStrong Growth and ImprovingQtr Ending 2026-06-30 · trend positive

Why Hold

Income statement and balance sheet are strong; cash flow is moderate.

Next earnings: 2026-10-29 (AMC), EPS Forecast: $0.66

What is strong
  • Revenue Growth is 15.54%
  • Operating Income Growth is 65.76%
  • Net Income Growth is 74.93%
  • Earnings Per Share (EPS) Growth is 75.52%
  • Net Margin is 20.12%
  • Current Debt to Net Income Ratio is 0.0
  • Total Debt to Total Assets Ratio is 0.0
  • Cash from Operations Growth is 77.05%
What to watch
  • Current Asset to Current Liability Ratio is 1.73
  • Debt Ratio is 0.59
  • Capital Expenditure is High
  • Net Increase in Cash is Negative

What changed

Score by quarter

Upgraded from Sell to Hold in the Mar 2026 quarter: 74.1 → 77.3 (+3.2). This quarter: -2.0.

607080Sep 2022Jun 2026

What the score is made of

Income statement88.4 -0.2
Balance sheet61.1 -2.3
Cash flow56.4 -7.7

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)4.97 Billion15.54 % growth
EPS2.5175.52 % growth
Profit margin20.12 %Profit per $1 of sales
P-E ratio—Not available
Market cap27.30 BillionShares × price
Debt-equity ratio—Not available
Dividend0.00Per share, annual
Next earnings2026-10-29AMC · EPS forecast $0.66
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About DEXCOM INC

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.

CEO
Kevin Sayer
Employees
5,328
Sector
Manufacturing
Exchange
Nasdaq
dexcom.com

Similar stocks

Loading…